Tải bản đầy đủ (.ppt) (18 trang)

STI Situation in Viet Nam

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (6.33 MB, 18 trang )


ViÖt Nam national institute of dermato-
venereology
ha noi, 2004
Sti situation in viet nam
Pham Van Hien
Nguyen Duy Hung
Pham Minh Phuong
Le Huu Doanh

STI situation in viet nam 1976-2003








1976 17,906 1990 19,678
1977 23,871 1991 21,029
1978 22,914 1992 19,826
1979 32,672 1993 54,403
1980 36,500 1994 49,212
1981 32,148 1995 44,138
1982 33,392 1996 42,934
1983 23,289 1997 70,918
1984 34,198 1998 144,274
1985 30,120 1999 110,619
1986 31,594 2000 112,141
1987 34,575 2001 156,262


1988 34,200 2002 183,927
1989 28.436 2003 142,956

STI situation in viet nam 1996-2003
42, 9 34
70,918
144,274
110,619
156,262
183,927
142,956
112,141
0
20, 000
40, 000
60, 000
80, 000
100,000
120,000
140,000
160,000
180,000
200,000
1996 1997 1998 1999 2000 2001 2002 2003

STI groups analysing 1995-2003



















 !
 !




""!
""!
!#!"$
!#!"$
#$
#$
#$
#$
#$
#$

%
%


"
"
"!!&
"!!&
" 
" 
&
&
"&"
"&"
#"$
#"$
# $
# $
!#$
!#$
#$
#$
%
%
 %
 %
&
&
!
!

"
"
&
&
!
!
"# $
"# $
#&$
#&$
!#!$
!#!$
#"$
#"$
!%
!%
"!
"!
!
!
&
&


""& "
""& "
&#$
&#$
"# $
"# $

&#"$
&#"$
# $
# $
%
%
%
%
&
&
 "
 "
 !
 !
&
&


&#!$
&#!$
#$
#$
#!$
#!$
#"$
#"$
%
%
&%
&%

&
&
 
 
 "
 "
&
&
&"
&"
#!$
#!$
#!$
#!$
# $
# $
# &$
# &$
%
%
&%
&%
&
&
!!
!!
"" 
"" 
"
"

&&
&&
#$
#$
# $
# $
&#&$
&#&$
&#!$
&#!$


%
%
&&
&&
&
&


  
  
 &
 &
!&
!&
#$
#$
#$
#$

#
#
&#"$
&#"$
&
&
&!&
&!&
!!
!!
&!
&!
"
"
"&
"&
&#&$
&#&$
"#!&$
"#!&$
!#$
!#$
#$
#$

STI groups analysing 1995-2003

Subgroups analysing of gonorrhea 1996-2003



'()*
'()*


)
)




" "&
" "&
"
"
"!!&
"!!&
 #$
 #$
&#! $
&#! $


 
 


!
!
# $
# $

#&$
#&$
!
!
 
 


!
!
#"$
#"$
#$
#$


 
 
"
"
 "
 "
#&$
#&$
#!$
#!$
&
&
"
"

&
&
 
 
# $
# $
#$
#$
&
&
!
!
&
&
!!
!!
#$
#$
#""$
#""$
&&
&&


&&
&&


#$
#$

#$
#$
&
&
!
!
!
!
!!
!!
# "$
# "$
#&$
#&$

Subgroups analysing of gonorrhea 1996-2003

Subgroups analysing of Syphilis 1996-2003
Year
Syphilis
I
Syphilis
II
Syphilis
III
Latent
Syphilis
Congenital
Syphilis
Unknown

Total

734 1,468 45 815 2 0 3,064
23.96% 47.91% 1.47% 26.60% 0.07% 0.00%

752 1,089 0 1,065 54 0 2,960
25.41% 36.79% 0.00% 35.98% 1.82% 0.00%
!
664 1,387 9 890 20 78 3,048
21.78% 45.51% 0.30% 29.20% 0.66% 2.56%

897 876 1 655 5 203 2,637
34.02% 33.22% 0.04% 24.84% 0.19% 7.70%
&
558 512 17 917 61 26 2,091
26.69% 24.49% 0.81% 43.85% 2.92% 1.24%
&
608 542 0 1,176 3 66 2,395
25.39% 22.63% 0.00% 49.10% 0.13% 2.76%
&&
439 355 0 1,707 0 0 2,501
17.55% 14.19% 0.00% 68.25% 0.00% 0.00%
&
485 601 0 1,802 4 0 2,827
16.77% 20.76% 0.00% 62.31% 0.14% 0.00%

congenital syphilis and ophthalmia
neonatorum 1995-2003
Year Congenital Syphilis Ophthalmia Neonatorum


4
4
32
32

2
2
140
140

53
53
15
15
!
20
20
66
66

5
5
46
46
&
74
74
20
20
&

3
3


26
26


&&
0
0
22
22
&
4
4
18
18

Subgroups analysing of Syphilis 1996-2003

STI analysing based on sex 1995-2003
Male Female Total

14,604 29,534 44,138
33.09% 66.91% )
%
8,228 34,706 42,934
19.16% 80.84% )
 %

9,591 61,327 70,918
13.52% 86.48% )
!%
19,809 124,465 144,274
13.73% 86.27% )
%
23,524 87,095 110,619
21.27% 78.73% )
&%
27,858 84,283 112,141
24.84% 75.16% )
&%
33,899 122,363 156,262
21.69% 78.31% )
&&
35,987 147,940 183,927
19.57% 80.43%
&
36,214 106,742 142,956
25.33% 74.67%

STI analysing based on sex 1995-2003

STI analysing based on age groups 1995-2003
Year <15 15-49 >49 Total

199
199
43,577
43,577

362
362
44,138
44,138
0.45%
0.45%
98.73%
98.73%
0.82%
0.82%

362
362
41,480
41,480
1,092
1,092
42,934
42,934
0.84%
0.84%
96.61%
96.61%
2.54%
2.54%

229
229
69,385
69,385

1,304
1,304
70,918
70,918
0.32%
0.32%
97.84%
97.84%
1.84%
1.84%
!
995
995
141,414
141,414
1,865
1,865
144,274
144,274
0.69%
0.69%
98.02%
98.02%
1.29%
1.29%

859
859
107,692
107,692

2,068
2,068
110,619
110,619
0.78%
0.78%
97.35%
97.35%
1.87%
1.87%
&
209
209
110,273
110,273
1,659
1,659
112,141
112,141
0.19%
0.19%
98.33%
98.33%
1.48%
1.48%
&
664
664
145,696
145,696

9,902
9,902
156,262
156,262
0.42%
0.42%
93.24%
93.24%
6.34%
6.34%
&&
265
265
181,415
181,415
2,247
2,247
183,927
183,927
0.14%
0.14%
98.63%
98.63%
1.22%
1.22%
&
422
422
137,618
137,618

4,916
4,916
142,956
142,956
0.30%
0.30%
96.27%
96.27%
3.44%
3.44%

STI analysing based on age groups 1995-2003
0.84%
96.61%
2.54%
0.32%
97.84%
1.84%
0.69%
98.02%
1.29%
0.78 %
97.35%
1.87 %
0.19%
98.33%
1.48%
0.42 %
93.24%
6.34 %

0.14%
98.63%
1.22%
0.30%
96.27%
3.44%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1996 1997 1998 1999 2000 2001 2002 2003
<15 15-49 >49 Tæng

Others Sti 2003

Antimicrobial susceptibility 1996-2003
1995 1996 1997 1998 1999 2000 2001 2002
2003
Penicillin
79.29 75.26 78.9 76.58 65.46
47.7
7
36.14 30.05

27.8
9
Cephalothin
1.03 0 1.56 2.53 5.15 4.55 4.5 3.75
16.9
6
Tetracycline
73.88 49.46 35.16 36.07 40.5 44.52 40.47 26.29
27.3
7
Chloramphenicol
14.4
3
10.75 5.47 13.29 20.61
23.2
3
16.36
24.4
1
55.8
0
Erythromycin
4.12 0 0 1.26 2.06 5.09 2.54 0.47
15.1
7
Ceftriaxone
0 0 0 0 0 0 0 0
0.00
Spectinomycine
0 0 0 0 0 0.64 0 0.5

0.00
Nalidixic acid
23.59 6.02 9.9 18.98 41.75 56.68 69.64 63.03
Ciprofloxacin
17.9 5.61 3.13 8.22 35.6 42.67 42.7 45.97
50.00
Beta-lactamase
76.28
73.1
2
62.5 62.65 51.03
47.1
3
35.54 28.64
27.8
9
Azythromycine
0

Antimicrobial susceptibility 1996-2003
75.26
78.9
76.58
65.46
47.77
0
1.56
2.53
5.15
4.55

4. 5
3. 75
16.96
0
0
0
0
0.64
0
0. 5
0
5.61
3.13
8.22
35.6
42.67
42.7
45.97
50
73.12
62.5
62.65
51.03
47.13
30.05
36.14
27.89
28.64
35.54
27.89

0
10
20
30
40
50
60
70
80
90
1996 1997 1998 1999 2000 2001 2002 2003
+' , ,-.
'' ,-.' /0'

Thank You
Thank You

Tài liệu bạn tìm kiếm đã sẵn sàng tải về

Tải bản đầy đủ ngay
×